Literature DB >> 29421811

Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.

Rong-Mei Wang1,2, Zhi-Bin Wang2, Yue Wang1,2, Wei-Ye Liu2, Ya Li1,2, Ling-Chang Tong2, Su Zhang1,2, Ding-Feng Su2, Yong-Bing Cao3, Ling Li2,3, Li-Chao Zhang1.   

Abstract

BACKGROUND/AIMS: Podocyte injury, especially podocyte apoptosis, plays a major role in early-stage diabetic nephropathy (DN). Swiprosin-1, also known as EF hand domain containing 2 (EFhd2), is a Ca2+-binding protein in different cell types. However, the function of swiprosin-1 in podocytes remains unknown.
METHODS: The expression and distribution of swiprosin-1 were investigated in the mouse renal glomerulus and conditionally immortalized mouse podocyte cell line MPC-5. The expression of swiprosin-1 was also detected in streptozotocin (STZ)-treated mice and MPC-5 cells treated with high glucose (HG). Nephrin and podocin were detected by immunohistochemistry and immunofluroscence. Collagen IV, transforming growth factor-β (TGF-β) and fibronectin mRNA expressions were assayed by real-time PCR. Apoptotic proteins and phosphorylation of p38 mitogen-activated protein kinase (MAPK) were detected by immunoblotting.
RESULTS: Swiprosin-1 was found to be expressed in podocytes of the mouse glomerulus and MPC-5 cells. Swiprosin-1 expression was increased in STZ-treated mice and MPC-5 cells treated with HG. In Swiprosin-1-/- diabetic mice, kidney/ body weight, urinary albumin, podocyte foot process effacement and glomerular basement membrane thickening were attenuated; the downregulation of nephrin and podocin expression in the glomerulus was inhibited; and the upregulation of collagen IV, TGF-β and fibronectin mRNA expression in the renal cortex was ameliorated as compared with those in diabetic swiprosin-1+/+ mice. In addition, the increased apoptosis of podocytes, proapoptotic protein expression and p38 phosphorylation in Swiprosin-1-/- diabetic mice were inhibited as compared with those in diabetic swiprosin-1+/+ mice. Knockdown of swiprosin-1 in MPC-5 cells reduced the apoptosis of podocytes, proapoptotic protein expression and p38 phosphorylation induced by HG. Targeted knockdown of p38 attenuated the increased apoptosis of MPC-5 cells over-expressing swiprosin-1.
CONCLUSION: Swiprosin-1 expression in podocytes of the mouse glomerulus played a critical role in early-stage DN. Swiprosin-1 deficiency in early DN attenuated mitochondria-dependent podocyte apoptosis induced by hyperglycemia or HG via p38 MAPK signaling pathway.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Apoptosis; Diabetic nephropathy; P38 MAPK; Podocyte; Swiprosin-1

Mesh:

Substances:

Year:  2018        PMID: 29421811     DOI: 10.1159/000487285

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  14 in total

1.  The aqueous extract of Lycopus lucidus Turcz exerts protective effects on podocytes injury of diabetic nephropathy via inhibiting TGF-β1 signal pathway.

Authors:  Shengfang Xie; Fengfeng Ge; Yuanzhang Yao; Wei Zhang; Shuopeng Wang; Min Zhang; Rongling Zhong; Liming Fang; Ding Qu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Conserved Noncoding Sequences Boost ADR1 and SP1 Regulated Human Swiprosin-1 Promoter Activity.

Authors:  Ramesh P Thylur; Sung Yong Ahn; Eunhea Jung; Chang-Duk Jun; Young-Min Hyun
Journal:  Sci Rep       Date:  2018-11-07       Impact factor: 4.379

3.  Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy.

Authors:  Guangyu Zhou; Xiaofei Zhang; Wanning Wang; Wenlong Zhang; Huaying Wang; Guangda Xin
Journal:  Med Sci Monit       Date:  2019-03-13

4.  Sirt6 Suppresses High Glucose-Induced Mitochondrial Dysfunction and Apoptosis in Podocytes through AMPK Activation.

Authors:  Yanqin Fan; Qian Yang; Yingjie Yang; Zhao Gao; Yiqiong Ma; Lu Zhang; Wei Liang; Guohua Ding
Journal:  Int J Biol Sci       Date:  2019-01-24       Impact factor: 6.580

5.  Network Pharmacology-Based Prediction of Mechanism of Shenzhuo Formula for Application to DKD.

Authors:  Xinmiao Wang; Haoyu Yang; Lili Zhang; Lin Han; Sha Di; Xiuxiu Wei; Haoran Wu; Haiyu Zhang; Linhua Zhao; Xiaolin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-17       Impact factor: 2.629

Review 6.  Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy.

Authors:  Lili Zhang; Zhige Wen; Lin Han; Yujiao Zheng; Yu Wei; Xinmiao Wang; Qing Wang; Xinyi Fang; Linhua Zhao; Xiaolin Tong
Journal:  J Diabetes Res       Date:  2020-07-08       Impact factor: 4.011

7.  Dexmedetomidine Ameliorates Acute Stress-Induced Kidney Injury by Attenuating Oxidative Stress and Apoptosis through Inhibition of the ROS/JNK Signaling Pathway.

Authors:  Yongping Chen; Xiujing Feng; Xueyuan Hu; Jichen Sha; Bei Li; Huayun Zhang; Honggang Fan
Journal:  Oxid Med Cell Longev       Date:  2018-09-03       Impact factor: 6.543

8.  Swiprosin-1/EFhD-2 Expression in Cardiac Remodeling and Post-Infarct Repair: Effect of Ischemic Conditioning.

Authors:  Zoltán Giricz; András Makkos; Rolf Schreckenberg; Jochen Pöling; Holger Lörchner; Krisztina Kiss; Péter Bencsik; Thomas Braun; Rainer Schulz; Péter Ferdinandy; Klaus-Dieter Schlüter
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

9.  Transforming growth factor-β1-induced podocyte injury is associated with increased microRNA-155 expression, enhanced inflammatory responses and MAPK pathway activation.

Authors:  Xintong Zheng; Qiuhong Zhong; Xu Lin; Xianjun Gu; Xiaoyan Ling; Zhao Liang; Qing Qin; Xiuri Du
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

10.  Gastrodin inhibits high glucose-induced inflammation, oxidative stress and apoptosis in podocytes by activating the AMPK/Nrf2 signaling pathway.

Authors:  Luyan Huang; Minghai Shao; Yan Zhu
Journal:  Exp Ther Med       Date:  2021-12-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.